Tessa Therapeutics Appoints David McIntyre as Chief Financial Officer
Mr. McIntyre brings over 25 years of global financial, operational and legal experience, including over…
Continue ReadingMr. McIntyre brings over 25 years of global financial, operational and legal experience, including over…
Continue ReadingTessa Therapeutics today announced the publication of results in the Journal of Clinical Oncology from…
Continue ReadingTessa Therapeutics today announced that Jeffrey H. Buchalter will assume the role of Chief Executive…
Continue ReadingRMAT designation follows positive proof-of-concept data from two independent Phase I/II clinical studies conducted by…
Continue Reading